Who owns Cogent Biosciences (COGT)? Superinvestor holders
1 superinvestor of the 157 tracked here holds Cogent Biosciences (COGT) in their latest 13F filing, a position of $544.3K. Andrew Spokes gives it the most weight: 0.00% of the reported portfolio.
Key facts
- Superinvestors holding it
- 1 of 157
- Biggest holder
- Andrew Spokes, $544.3K
- Largest weight
- Andrew Spokes, 0.00%of their portfolio
- Combined value
- $544.3K
- Bought last quarter
- 0
- Sold last quarter
- 0
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Andrew SpokesFarallon Capital Management | 0.00% | $544.3K | 17K | No change | 0 | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 17K | $544.3K | 0 | 0 |
| Q2 2026 | 157 | 1 | 17K | $657.9K | 0 | 0 |
| Q1 2026 | 157 | 2 | 2.27M | $87.3M | 1 | 1 |
| Q4 2025 | 157 | 2 | 2.23M | $79.3M | 1 | 0 |
| Q3 2025 | 157 | 2 | 1.08M | $15.5M | 1 | 0 |
| Q2 2025 | 157 | 1 | 17K | $122.1K | 0 | 0 |
| Q1 2025 | 156 | 1 | 17K | $101.8K | 0 | 0 |
| Q4 2024 | 156 | 1 | 17K | $132.6K | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Andrew Spokes | 17K | 17K | 17K | 17K | 17K | 17K | 17K | 17K |
| Brandon Haley | · | — | 2.25M | — | — | — | — | — |
| Stanley Druckenmiller | · | — | — | 2.21M | 1.06M | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own COGT?
In their latest 13F filings: Andrew Spokes (0.00% of the portfolio, $544.3K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Cogent Biosciences (COGT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/COGT/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to COGT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.